Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
COVID-19 vaccination is not associated with heart transplant-specific adverse events
SARS-CoV-2 Seroprevalence Up From Dec. 2021 to Feb. 2022
By February 2022, seroprevalence reached 75.2 percent among children aged 0 to 11 years, 74.2 percent for teens aged 12 to 17 years
U.S. Teen Suicides Up During Pandemic
Authors say interventions to alleviate downstream consequences of the pandemic are needed
RSV Prefusion F Protein-Based Immunization Studied in Pregnancy
Bivalent RSVpreF vaccine given during pregnancy elicits neutralizing antibody responses with efficient transplacental transfer
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
Initial two-dose series of the Pfizer vaccine was authorized for that age group in October
Antibiotic Use in Under 2s May Reduce Antibody Response to Vaccines
Possible negative association of history of antibiotic prescriptions with vaccine-induced immunity seen in young children
Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose
In large cohort, there were 5.55 excess events per 100,000 vaccinees after BNT162b2 and 18.39 after mRNA-1273
Natural COVID-19 Immunity Produces Protection Similar to Vaccines
Similar natural protection seen against mild and severe disease
Food Insecurity Tied to Delayed, Forgone Medical Care
Food insecurity during the pandemic disproportionately affected non-White and low-income individuals
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
